2019 Cross-Border Healthcare Innovation Summit

February 12, 2019

February 12, 2019

8:30 am To 1:00 pm

300 Madison Avenue, New York, NY 10017



    Event Description


    As BIO CEO & Investor Conference is around the corner, BioKatalyst and MSQ Ventures collaborate together and invite you to the 2019 Cross-Border Healthcare Innovation Summit, sponsored by Dorsey & Whitney and PwC. On February 12th, we are so honored to have the distinguished speakers Seamus Jiang from PwC, Sean X. Hu from BioKatalyst, Kate Merton from Johnson & Johnson JLABS, John Xu from Jemincare USA, Mark Tang from Good Health Capital, and Catherine X. Pan-Giordano from Dorsey & Whitney LLP to discuss the China market dynamics, healthcare sector trends under new environment, latest applications, and other related matters.   The conference aims to bring the latest information to practitioners and individuals who are genuinely excited about healthcare and provide an opportunity to be introduced to top-tier biotechnology and pharmaceutical companies.   Industry Background: Healthcare is an evolving sector in China, especially within the recent years. The regulatory pathway, drug approval process, and the retail sectors have gone through several reformations. New policies by China National Medical Products Administration (NMPA) encourage R&D for novel therapies and technology transfers through expedited review processes and favorable clinical and approval standards, in order to solve high unmet medical needs in areas such as cancer, immunology, neurology, and rare diseases. Agenda: Registration will end at 10am Monday, February 11th, 2019. For any questions, please email us at Tickets@msqventures.com


    MSQ Ventures

    About the Organizers

    MSQ Ventures is a cross-border M&A and strategic advisory firm focused on partnering U.S. based technology, consumer, and healthcare companies with strategic Chinese corporate and institutional investors.  We like innovative companies that offer differentiated solutions and have forward-thinking mindset for their China strategy.  We provide our partner management teams with the necessary strategic, operational and financial resources to accelerate growth and realize their potential in China. Our team brings extensive cross-border transaction experience, deep local knowledge, and strong relationships to further connect our partner companies with other Chinese strategic and financial investors.     *Our previous 2018 conferences include MSQ Annual China Cross-Border Roadshow during JP Morgan’s 37th Healthcare Conferencein San Francisco, MSQ Cross-border Healthcare Investment Tourin China.

    Visited 160 times, 1 Visit today